Group One Trading
XERS icon

Group One Trading’s Xeris Biopharma Holdings XERS Stock Holding History

Group One Trading’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.27M Buy
218,145
+94,584
+77% +$627K ﹤0.01% 2485
2025
Q4 		$970K Buy
123,561
+117,537
+1,951% +$925K ﹤0.01% 2920
2025
Q3 		$49K Buy
+6,024
New +$40K ﹤0.01% 5984
2024
Q1 		– Sell
-78,951
Closed -$204K – 8079
2023
Q4 		$186K Buy
78,951
+12,781
+19% +$23.6K ﹤0.01% 3933
2023
Q3 		$123K Buy
66,170
+26,097
+65% +$59.8K ﹤0.01% 4262
2023
Q2 		$105K Sell
40,073
-55,785
-58% -$142K ﹤0.01% 4577
2023
Q1 		$156K Buy
95,858
+41,851
+77% +$52.4K ﹤0.01% 3889
2022
Q4 		$71.8K Buy
+54,007
New +$76.2K ﹤0.01% 4722
2020
Q3 		– Sell
-2,180
Closed -$8.72K – 6603
2020
Q2 		$6K Buy
2,180
+1,700
+354% +$5.92K ﹤0.01% 5327
2020
Q1 		$1K Sell
480
-300
-38% -$1.29K ﹤0.01% 5118
2019
Q4 		$6K Hold
780
– – ﹤0.01% 4728
2019
Q3 		$8K Buy
+780
New +$8.77K ﹤0.01% 4659

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's XERS Position: Q1 2026 in Review

Group One Trading increased its Xeris Biopharma Holdings (XERS) stake by 77% in Q1 2026, buying an estimated $627K and bringing the position to 218,145 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2485.

Group One Trading first reported a position in XERS in Q3 2019 and has held it in 12 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Group One Trading held 218,145 shares of Xeris Biopharma Holdings worth $1.27M as of Q1 2026.
  • Group One Trading bought 94,584 Xeris Biopharma Holdings shares in Q1 2026, an estimated $627K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2485 holding.
  • Group One Trading first reported a position in Xeris Biopharma Holdings in Q3 2019 and has held it in 12 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.